Indo National Limited has acquired an additional 0.41% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹25,01,968. The investment brings the listed company’s total holding in the target entity to 62.28% on a fully diluted basis.

The acquisition was executed through a cash subscription of 178 equity shares at ₹14,056 per share. This price was determined based on a valuation report issued by a registered valuer on August 21, 2026. The transaction does not constitute a related-party transaction, and no promoters or group companies hold an interest in MMSPL.

Investment Rationale and Timeline

Indo National stated that the acquisition aims to facilitate business growth, generate revenue, and earn profit through the expansion of its operations. The company expects the acquisition process to be completed by FY27-28. No governmental or regulatory approvals are required for this transaction.

MMSPL is engaged in the manufacturing, distribution, and servicing of Air Monitoring Systems and Air Purifiers. Incorporated on June 7, 2020, the entity operates solely within India.

Financial Performance of Target

The financial data disclosed in the filing highlights significant revenue growth for MMSPL in the most recent fiscal year.

What the Numbers Show

MMSPL’s turnover surged to ₹1.45 crore in FY26, marking a substantial increase from ₹35.41 lakh in FY25. This represents a recovery and expansion after a dip in FY24 turnover to ₹47.68 lakh. The sharp rise in FY26 suggests accelerated business activity or order conversion in the air monitoring segment during that period.

Indo National has scheduled its 53rd Annual General Meeting for September 28, 2026, proposing a dividend of ₹3.75 per equity share for FY26. The payout represents 75% of the ₹5 face value and is set against a backdrop of declining profitability.

The company reported a pre-tax loss of ₹996.71 lakh for the year ended March 31, 2026, reversing a profit of ₹106.39 lakh recorded in FY25. Management attributed the deterioration to steep increases in raw material costs, a shift in sales volume mix, and the conversion of battery-operated torches to rechargeable models.

Financial Performance

Despite the operational loss, the company’s net worth stood at ₹21,210.24 lakh as on March 31, 2026, supporting a book value per share of ₹282.80. The board indicated that adequate steps have been taken to recover profits, citing considerable demand recovery in Q1FY27.

What the Numbers Show

The declaration of a dividend yielding 75% of face value amidst a significant pre-tax loss highlights a reliance on retained earnings or cash reserves rather than current period profitability. With net worth remaining robust at over ₹2,100 crore, the payout does not immediately threaten solvency, but it underscores a divergence between operational performance and shareholder returns.

Corporate Governance Updates

Shareholders will vote on the re-appointment of Ms. Suneeta Reddy as a Non-Executive Director. She retires by rotation and offers herself for re-appointment. Ms. Reddy holds 119,160 shares in the company and brings 31 years of experience, primarily in healthcare services.

The meeting will also seek approval for:

• Remuneration of ₹1,00,000 plus out-of-pocket expenses to M/s. B. Thulasiram & Co. as Cost Auditor for FY27.
• Payment of profit-related commission to Non-Executive Independent Directors for FY26 through FY28, capped at 1% of net profits or ₹5,00,000, whichever is higher.

The AGM will be conducted via Video Conferencing. Remote e-voting through CDSL will be open from September 25 to September 27, 2026. The register of members will remain closed from September 22 to September 28, 2026.